(1S)-(+)-(10-Camphorsulfonyl) oxaziridine CAS 104322-63-6 Mimọ ≥98.5% (HPLC) Iwa mimọ to gaju

Apejuwe kukuru:

Orukọ: (1S)-(+)-(10-Camphorsulfonyl) oxaziridine

Awọn itumọ ọrọ sisọ: (2R,8aS)-(+)-(Camphorylsulfonyl) oxaziridine

CAS: 104322-63-6

Irisi: Pa-White tabi Pale Yellow Crystalline Powder

Mimọ: ≥98.5% (HPLC)

Chiral Compounds, Commercial Production


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Olupese pẹlu Iwa-mimọ giga ati Didara Idurosinsin
(1S)-(+)-(10-Camphorsulfonyl) oxaziridine CAS 104322-63-6
(1R)-(-)-(10-Camphorsulfonyl) oxaziridine CAS 104372-31-8
Awọn akojọpọ Chiral, Didara to gaju, Ṣiṣejade Iṣowo

Kemikali Properties:

Orukọ Kemikali (1S)-(+)-(10-Camphorsulfonyl) oxaziridine
Awọn itumọ ọrọ sisọ (1S)-(+)-(Camphorylsulfonyl) oxaziridine;(2R,8aS)-(+)-(Camphorylsulfonyl) oxaziridine
Nọmba CAS 104322-63-6
NỌMBA CAT RF-CC267
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C10H15NO3S
Òṣuwọn Molikula 229.3
Sowo Ipò Sowo Labẹ Ibaramu otutu
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Pa-White tabi Bia ofeefee Crystalline Powder
Mimo ≥98.5% (HPLC)
Ojuami Iyo 168.0 ~ 172.0 ℃
Yiyi pato [a] D20 +43.0° ~ +47.0° (C=2.3, Ninu CHCl3)
Pipadanu lori Gbigbe ≤1.0%
Aloku lori Iginisonu ≤0.30%
Awọn Irin Eru (Pb) ≤20ppm
Igbeyewo Standard Standard Enterprise
Lilo Awọn akojọpọ Chiral;elegbogi Intermediates

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, Ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.

Awọn anfani:

1

FAQ:

Ohun elo:

Shanghai Ruifu Kemikali Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti (1S)-(+) (10-Camphorsulfonyl) oxaziridine (CAS: 104322-63-6) pẹlu didara to gaju.

(1S)-(+)-(10-Camphorsulfonyl) oxaziridine (CAS: 104322-63-6) jẹ itọsẹ Camphor ti o wulo, agbedemeji sintetiki ti o wulo.Ti a lo fun hydroxylation asymmetric.

(1S)-(+)-(10-Camphorsulfonyl) oxaziridine (CAS: 104322-63-6) le ṣee lo:
Lati se iyipada ketone prochiral enolates sinu optically ti nṣiṣe lọwọ α-hydroxy ketones nipasẹ enantioselective asymmetric oxidation.
Ninu iṣelọpọ ti thymidine oligonucleotides ti a ti sopọ nipasẹ awọn pyrophosphates.
Ninu iṣelọpọ asymmetric ti proton pump inhibitors bi (R) -Rabeprazole sodium ati (R) -Lansoprazole sodium lati iyọ DBU ti o baamu ti sulfide prochiral.
Ni igbaradi ti phosphonoacetate ati thiophosphonoacetate oligodeoxynucleotides nipa oxidizing phosphinoacetate ti o baamu.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa